News

Meitheal Pharmaceuticals has Bortezomib for Injection Now Available.

Meitheal Pharmaceuticals Earns Great Place to Work Certification™ and Is Named One of Best Places to Work in Illinois

Meitheal Pharmaceuticals has Decitabine for Injection Now Available.

Meitheal Pharmaceuticals has Pemetrexed for Injection, USP Now Available.

Meitheal Pharmaceuticals Announces Membership in The Association for Accessible Medicines

Meitheal Pharmaceuticals is pleased to announce that Haloperidol Decanoate Injection is Now Available.

Meitheal Pharmaceuticals has Succinylcholine Chloride Injection, USP Now Available.

Meitheal Pharmaceuticals Announces Findings from Collaborative Research Study with Premier Inc. Evaluating Anticoagulant Treatment of COVID-19 Patients

Customer Notification Recall Communication Letter

Urgent: Glycopyrrolate Injection, USP 4mg per 20mL RECALL

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection, USP 10mg per 5mL Due to Mislabeling